Levofenfluramine (INN), or (-)-3-trifluoromethyl-N-ethylamphetamine, also known as (-)-fenfluramine or (R)-fenfluramine, is a drug of the amphetamine family that, itself (i.e., in enantiopure form), was never marketed. It is the levorotatory enantiomer of fenfluramine, the racemic form of the compound, whereas the dextrorotatory enantiomer is dexfenfluramine. Both fenfluramine and dexfenfluramine are anorectic agents that have been used clinically in the treatment of obesity (and hence, levofenfluramine has been as well since it is a component of fenfluramine). However, they have since been discontinued due to reports of causing cardiovascular conditions such as valvular heart disease and pulmonary hypertension,adverse effects that are likely to be caused by excessive stimulation of 5-HT2B receptors expressed on heart valves.




This page contains text from Wikipedia, the Free Encyclopedia - http://en.wikipedia.org/wiki/Levofenfluramine

This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.